Cargando…
Monitoring left ventricular assist device parameters to detect flow- and power-impacting complications: a proof of concept
AIMS: The number of patients on left ventricular assist device (LVAD) support increases due to the growing number of patients with end-stage heart failure and the limited number of donor hearts. Despite improving survival rates, patients frequently suffer from adverse events such as cardiac arrhythm...
Autores principales: | Moazeni, Mehran, Numan, Lieke, Szymanski, Mariusz K, Van der Kaaij, Niels P, Asselbergs, Folkert W, van Laake, Linda W, Aarts, Emmeke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689906/ https://www.ncbi.nlm.nih.gov/pubmed/38045436 http://dx.doi.org/10.1093/ehjdh/ztad062 |
Ejemplares similares
-
Developing a personalized remote patient monitoring algorithm: a proof-of-concept in heart failure
por: Moazeni, Mehran, et al.
Publicado: (2023) -
Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe
por: Numan, Lieke, et al.
Publicado: (2023) -
Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021) -
Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023) -
Multilevel analysis quantifies variation in the experimental effect while optimizing power and preventing false positives
por: Aarts, Emmeke, et al.
Publicado: (2015)